Catecholaminergic control of mitogen-activated protein kinase signaling in paraventricular neuroendocrine neurons in vivo and in vitro: A proposed role during glycemic challenges

Journal of Neuroscience

Volumn 27, Issue 27, 2007, Pages 7344-7360

  Khan, Arshad M ^a   Ponzio, Todd A ^b,c   Sanchez Watts, Graciela ^a   Stanley, B Glenn ^b   Hatton, Glenn I ^b   Watts, Alan G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

1 adrenoceptor; Catecholamine; CRH; ERK1; ERK2; Hypoglycemia; MEK; Neuroendocrine; Norepinephrine; p44 42 MAP kinases; Parvicellular; PVH; Signal transduction; Stimulus response coupling; Stress

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEOXYGLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NORADRENALIN; PRAZOSIN; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANTERIOR HYPOTHALAMUS; ARTICLE; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYPOGLYCEMIA; IMMUNOREACTIVITY; MALE; NERVE CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHOMBENCEPHALON; SIGNAL TRANSDUCTION;

ANIMALS; CATECHOLAMINES; DEOXYGLUCOSE; INSULIN; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROSECRETORY SYSTEMS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34447132204     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0873-07.2007     Document Type: Article

References (102)

1. Ambach G, Palkovits M (1979) The blood supply of the hypothalamus in the rat. In: Handbook of the hypothalamus, Vol 1, Anatomy of the hypothalamus (Morgane PJ, Panksepp J, eds), pp 267-377. New York: Marcel Dekker.
2. Anderson NG, Maller JL, Tonks NK, Sturgill TW (1990) Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343:651-653.
3. Armstead WM (2006) Differential activation of ERK, p38, and JNK MAPK by nociceptin/orphanin FQ in the potentiation of prostaglandin cerebrovasoconstriction after brain injury. Eur J Pharmacol 529:129-135.
4. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123:493-505.
5. Belin V, Moos F (1986) Paired recordings from supraoptic and paraventricular oxytocin cells in suckled rats: recruitment and synchronization. J Physiol (Lond) 377:369-390.
6. Belin V, Moos F, Richard P (1984) Synchronization of oxytocin cells in the hypothalamic paraventricular and supraoptic nuclei in suckled rats: direct proof with paired extracellular recordings. Exp Brain Res 57:201-203.
7. Bitner RS, Nikkel AL, Otte S, Martino B, Barlow EH, Bhatia P, Stewart AO, Brioni JD, Decker MW, Moreland RB (2006) Dopamine D4 receptor signaling in the rat paraventricular hypothalamic nucleus: evidence of natural coupling involving immediate early gene induction and mitogen protein kinase phosphorylation. Neuropharmacology 50:521-531.
8. Boudaba C, Tasker JG (2006) Intranuclear coupling of hypothalamic magnocellular nuclei by glutamate synaptic circuits. Am J Physiol 291:R102-R111.
9. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouysségur J (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674.
10. 2-adrenoceptors mediating noradrenergic modulation of spontaneous inhibitory postsynaptic currents in the hypothalamic paraventricular nucleus. J Neuroendocrinol 16:450-457.
11. Cobb MH, Goldsmith EJ (1995) How MAP kinases are regulated. J Biol Chem 270:14843-14846.
12. Cobb MH, Goldsmith EJ (2000) Dimerization in MAP-kinase signalling. Trends Biochem Sci 25:7-9.
13. Cohen Z, Molinatti G, Hamel E (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 17:894-904.
14. Cole RL, Sawchenko PE (2002) Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci 22:959-969.
15. Daftary SS, Boudaba C, Tasker JG (2000) Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience 96:743-751.
16. 1b adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci 19:10098-10106.
17. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ (1997) Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem 272:19125-19132.
18. Douglas WW, Rubin RP (1961) Mechanism of nicotinic action at the adrenal medulla: calcium as a link in stimulus-secretion coupling. Nature 192:1087-1089.
19. Duncia JV, Santella III JB, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun J-H, Earl RA, Tabaka AC, Teleha CA, Blom KF, Favata MF, Manos EJ, Daulerio AJ, Stradley DA, Horiuchi K, Copeland RA, Scherle PA, Trzaskos JM, et al. (1998) MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett 8:2839-2844.
20. Eiden LE, Giraud P, Dave JR, Hotchkiss AJ, Affolter HU (1984) Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 312:661-663.
21. English JM, Cobb MH (2002) Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23:40-45.
22. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
23. Flood DG, Finn JP, Walton KM, Dionne CA, Contreras PC, Miller MS, Bhat RV (1998) Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J Comp Neurol 398:373-392.
24. Gillard ER, Khan AM, Grewal RS, Mouradi B, Wolfsohn SD, Stanley BG (1998) The second messenger cAMP elicits eating by an anatomically specific action in the perifornical hypothalamus. J Neurosci 18:2646-2652.
25. Gordon GRJ, Bains JS (2005) Noradrenaline triggers multivesicular release at glutamatergic synapses in the hypothalamus. J Neurosci 25:11385-11395.
26. Gordon GRJ, Baimoukhametova DV, Hewitt SA, Kosala WRA, Rajapaksha JS, Fisher TE, Bains JS (2005) Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci 8:1078-1086.
27. Gorton LM, Bohland MA, Khan AM, Sanchez-Watts G, Donovan CM, Watts AG (2006) Diurnal difference in HPA hormone responses to hypoglycemia is not a function of changing hypoglycemic thresholds. Paper presented at 66th Annual Meeting of American Diabetes Association, Washington, DC, June.
28. Grollman A (1958) Pharmacology and therapeutics: a textbook for students and practitioners of medicine and its allied professions. Philadelphia: Lea and Febiger.
29. Grossman SP (1960) Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus. Science 132:301-302.
30. Hatton GI, Doran AD, Salm AK, Tweedle CD (1980) Brain slice preparation: hypothalamus. Brain Res Bull 5:405-414.
31. Helmreich DL, Itoi K, Lopez-Figueroa MO, Akil H, Watson SJ (2001) Norepinephrine-induced CRH and AVP gene transcription within the hypothalamus: differential regulation by corticosterone. Mol Brain Res 88:62-73.
32. Inouye K, Chan O, Riddell MC, Akirav E, Matthews SG, Vranic M (2002) Mechanisms of impaired hypothalamic-pituitary-adrenal (HPA) function in diabetes: reduced counterregulatory responsiveness to hypoglycaemia. Diabetes Nutr Metab 15:348-355.
33. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abd K, Demura H (1994) Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 135:2177-2182.
34. Itoi K, Helmreich DL, Lopez-Figueroa MO, Watson SJ (1999) Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 19:5464-5472.
35. Ito-Ishida A, Kakegawa W, Yuzaki M (2006) ERK1/2 but not p38 MAP kinase is essential for the long-term depression in mouse cerebellar slices. Eur J Neurosci 24:1617-1622.
36. Jacobowitz DM, Winsky L, Detera-Wadleigh SD (1996) Cellular expression of MAP 2 kinase in rat brain. Histochem Cell Biol 106:303-310.
37. 1A receptor-mediated phosphorylation of ERK and neuroendocrine responses in rats. Soc Neurosci Abstr 32:33.21.
38. Khan AM, Watts AG (2003) Norepinephrine rapidly elevates CRH hnRNA, c-Fos mRNA and levels of phosphorylated MAP kinases (ERK 1 and 2) in hypothalamic parvicellular paraventricular neurons in vivo. Soc Neurosci Abstr 29:397.18.
39. Khan AM, Watts AG (2004) Intravenous 2-deoxy-D-glucose injection rapidly elevates levels of the phosphorylated forms of p44/p42 mitogen activated protein kinases (extracellularly regulated kinases 1 and 2) in rat hypothalamic parvicellular paraventricular neurons. Endocrinology 145:351-359.
40. Khan AM, Watts AG (2005a) Tracking intracellular events associated with glucoprivic challenge in three forebrain regions that contain CRH neurons receiving hindbrain noradrenergic input. American Neuroendocrine Society, 2005, Workshop on the Neuroendocrinology of Stress. Poster 29.
41. Khan AM, Watts AG (2005b) Glucoprivic challenge is associated with elevated levels of phosphorylated signaling intermediates in discrete forebrain regions: immunofluorescence studies of ERK1/2 and CREB. Soc Neurosci Abstr 31:634.15.
42. Khan AM, Currás MC, Dao J, Jamal FA, Turkowski CA, Goel RK, Gillard ER, Wolfsohn SD, Stanley BG (1999) Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidence. Am J Physiol 276:R880-R891.
43. Khan AM, Cheung HH, Gillard ER, Palarca JA, Welsbie DS, Gurd JW, Stanley BG (2004) Lateral hypothalamic signaling mechanisms underlying feeding stimulation: differential contributions of Src family tyrosine kinases to feeding triggered either by NMDA injection or by food deprivation. J Neurosci 24:10603-10615.
44. Khan AM, Ponzio TA, Hatton GI, Watts AG (2006) Confocal imaging of acute hypothalamic slices maintained in vitro reveals rapid noradrenergic recruitment of MAP kinases in CRH neuroendocrine neurons of the hypothalamic paraventricular nucleus (PVH): comparison with central injection studies. Front Neuroendocrinol 27:148-149.
45. Kim S-J, Kahn CR (1997) Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. Biochem J 323:621-627.
46. Kovacs KJ, Sawchenko PE (1996) Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16:262-273.
47. Leibowitz SF, Sladek C, Spencer L, Tempel D (1988) Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull 21:905-912.
48. Leibowitz SF, Diaz S, Tempel D (1989) Norepinephrine in the paraventricular nucleus stimulates corticosterone release. Brain Res 496:219-227.
49. Lesscher HMB, Burbach JPH, Van Ree JM, Gerrits MAFM (2003) ERK1/2 activation in rat ventral tegmental area by the μ-opioid agonist fentanyl: an in vitro study. Neuroscience 116:139-144.
50. Levin MC, Sawchenko PE, Howe PRC, Bloom SR, Polak JM (1987) Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 261:562-582.
51. Lind RW, Swanson LW, Ganten D (1984) Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat. Brain Res 321:209-215.
52. Liposits Z, Phelix C, Paull WK (1986a) Electron microscopic analysis of tyrosine hydroxylase, dopamine-beta-hydroxylase and phenylethanolamine-N- methyltransferase immunoreactive innervation of the hypothalamic paraventricular nucleus in the rat. Histochemistry 84:105-120.
53. Liposits Z, Phelix C, Paull WK (1986b) Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study. Histochemistry 84:201-205.
54. Mandell JW (2003) Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology. Am J Pathol 163:1687-1698.
55. McCaleb ML, Myers RD (1982) 2-Deoxy-D-glucose and insulin modify release of norepinephrine from rat hypothalamus. Am J Physiol 242:596-603.
56. Meyer-Spasche A, Piggins HD (2004) Vasoactive intestinal polypeptide phase-advances the rat suprachiasmatic nuclei circadian pacemaker in vitro via protein kinase A and mitogen-activated protein kinase. Neurosci Lett 358:91-94.
57. Muglia LJ, Jacobson L, Luedke C, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA (2000) Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105:1269-1277.
58. Müller MB, Zimmerman S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MSD, Droste SK, Kühn R, Reul JMHM, Holsboer F, Wurst W (2003) Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptations to stress. Nat Neurosci 6:1100-1107.
59. Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431:195-199.
60. Myers RD (1966) Injection of solutions into cerebral tissue: relation between volume and diffusion. Physiol Behav 1:171-174.
61. Myers RD (1974) Handbook of drug and chemical stimulation of the brain: behavioral, pharmacological and physiological aspects. New York: Van Nostrand Reinhold.
62. Nadjar A, Combe C, Busquet P, Dantzer R, Parnet P (2005) Signaling pathways of interleukin-1 actions in the brain: anatomical distribution of phospho-ERK1/2 in the brain of rat treated systemically with interleukin-1β. Neuroscience 134:921-932.
63. Nagatani S, Tsukamura H, Murahashi K, Bucholtz DC, Foster DL, Maeda K-I (1996) Paraventricular norepinephrine release mediates glucoprivic suppression of pulsatile luteinizing hormone secretion. Endocrinology 137:3183-3186.
64. Obrietan K, Gao XB, van den Pol AN (2002) Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism - a positive feedback circuit in developing neurons. J Neurophysiol 88:1005-1015.
65. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4. San Diego: Academic.
66. Peinado JM, Myers RD (1987) Norepinephrine release from PVN and lateral hypothalamus during perfusion with 2-DG or insulin in the sated and fasted rat. Pharmacol Biochem Behav 27:715-721.
67. Peyssonnaux C, Eychène A (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 93:53-62.
68. Ponzio TA, Hatton GI (2005) Adenosine postsynaptically modulates supraoptic neuronal excitability. J Neurophysiol 93:535-547.
69. Pouysségur J, Lenormand P (2003) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270:3291-3299.
70. Raby WN, Renaud LP (1989) Dorsomedial medulla stimulation activates rat supraoptic oxytocin and vasopressin neurones through different pathways. J Physiol (Lond) 417:279-294.
71. Raichle ME, Hartman BK, Eichling JO, Sharpe LG (1975) Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci USA 72:3726-3730.
72. Rapp KL, Khan AM, Watts AG (2006) Catecholaminergic afferents are required for hypothalamic parvicellular paraventricular neurons to transduce signals associated with hypoglycemia into p44/42 MAP kinase phosphorylation events. Soc Neurosci Abstr 32:355.9.
73. Ray LB, Sturgill TW (1988) Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci USA 85:3753-3757.
74. Ritter S, Llewellyn-Smith I, Dinh TT (1998) Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res 805:41-54.
75. Ritter S, Bugarith K, Dinh TT (2001) Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 432:197-216.
76. Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, Pedrow C (2003) Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 144:1357-1367.
77. Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert TD, Cobb MH (1993) Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 268:5097-5106.
78. Ross JA (2007) Colour-blindness: how to alienate a grant reviewer. Nature 445:593.
79. Saphier D, Feldman S (1987) Electrophysiology of supraopticoparaventricular nucleus connections in the rat. Exp Brain Res 69:60-66.
80. Saphier D, Feldman S (1989) Adrenoceptor specificity in the central regulation of adrenocortical secretion. Neuropharmacology 28:1231-1237.
81. Sausen GN, Engelhardt VA, Middleton WJ (1958) Cyanocarbon chemistry. VII. Tricyanoethylenes. J Am Chem Soc 80:2815-2822.
82. Sawchenko PE, Swanson LW (1982) Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205:260-272.
83. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM (1985) Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241:138-153.
84. Schwanzel-Fukuda M, Jorrell JI, Pfaff DW (1984) Localization of forebrain neurons which project directly to the medulla and spinal cord of the rat by retrograde tracing with wheat germ agglutinin. J Comp Neurol 226:1-20.
85. Silverman AJ, Hoffman DL, Zimmerman EA (1981) The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull 6:47-61.
86. Smith ER, Smedberg JL, Rula ME, Xu X-X (2004) Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. J Cell Biol 164:689-699.
87. Swanson LW (1991) Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res 87:181-200.
88. Swanson LW (1998) Brain maps: structure of the rat brain, Ed 2. Amsterdam: Elsevier.
89. Swanson LW, Kuypers HG (1980) The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 194:555-570.
90. Swanson LW, Connelly MA, Hartman BK (1977) Ultrastructural evidence for central monoaminergic innervation of blood vessels in the paraventricular nucleus of the hypothalamus. Brain Res 136:166-173.
91. Szafarczyk A, Malaval F, Laurent A, Gibaud R, Assenmacher I (1987) Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology 121:883-892.
92. Tanimura SM, Sanchez-Watts G, Watts AG (1998) Peptide gene activation, secretion, and steroid feedback during stimulation of rat neuroendocrine corticotropin-releasing hormone neurons. Endocrinology 139:3822-3829.
93. Teruyama R, Armstrong WE (2002) Changes in the active membrane properties of rat supraoptic neurons during pregnancy and lactation. J Neuroendocrinol 14:933-944.
94. Thomas KL, Hunt SP (1993) The regional distribution of extracellularly regulated kinase-1 and-2 messenger RNA in the adult rat central nervous system. Neuroscience 56:741-757.
95. van der Kooy D, Koda LY, McGinty JF, Gerfen CR, Bloom FE (1984) The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in rat. J Comp Neurol 224:1-24.
96. Vanhoose AM, Emery M, Jimenez L, Winder DG (2002) ERK activation by G protein-coupled receptors in mouse brain is receptor identity-specific. J Biol Chem 277:9049-9053.
97. Watts AG (2005) Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: a complexity beyond negative feedback. Front Neuroendocrinol 26:109-130.
98. Watts AG, Sanchez-Watts G (1995) Physiological regulation of peptide messenger RNA colocalization in rat hypothalamic paraventricular medial parvicellular neurons. J Comp Neurol 352:501-514.
99. Watts AG, Kelly AB, Sanchez-Watts G (1995) Neuropeptides and thirst: the temporal response of corticotropin-releasing hormone and neurotensin/ neuromedin N gene expression in rat limbic forebrain neurons to drinking hypertonic saline. Behav Neurosci 109:1146-1157.
100. Wick AN, Drury DR, Nakada HI, Wolfe JB (1957) Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 224:963-969.
101. Yuill EA, Hoyda TD, Ferri CC, Zhou Q-Y, Ferguson AV (2007) Prokineticin 2 depolarizes paraventricular nucleus magnocellular and parvocellular neurons. Eur J Neurosci 25:425-434.
102. 1- adrenergic receptor subtypes. J Neurochem 72:2388-2396.